Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride-loaded nanoparticles were successfully created for potential improved hair growth treatment.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Minoxidil and spironolactone can improve hair growth, but responses vary and side effects are common.

Female hair loss patients more likely to have dry eye and gland issues.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

FPHL affects hair density and diameter, causing visible hair loss in older women.

Androgens can both increase and decrease hair growth in different parts of the body.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Hair loss linked to higher heart disease risk in both men and women.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Finasteride improves hair loss in women with hyperandrogenism.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

New alopecia treatments aim for better results and fewer side effects.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.